EUCTR2017-003036-37-AT进行中（未招募）1 期
A double-blind, placebo-controlled pilot trial to investigate the administration of von Willebrand factor concentrate (Willfact®, LFB France) in adult patients during extracorporeal membrane oxygenation - Von Willebrand factor concentrate during ECMO support
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Patients with the need of veno-arterial or veno-venous ECMO for a minimum of 48 hours
- •- Age = 18 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Patient with known thromboembolic event in the last 30 days
- •- Inevitable lethal course
- •- Quick < 30 % due to severe liver failure
- •- Bleeding tendency (e.g. hemophilia)
- •- Pregnancy
- •- Patient with known refusal of a participation in this clinical trial
- •- Active participation in another clinical trial
- •- Any condition, including the presence of laboratory abnormalities, which would place the subject at unacceptable risk if he/she were to participate in the study or confound the ability to interpret data from the study
研究者
相似试验
已完成
不适用
A double-blind, placebo-controlled, pilot study to assess the safety and preliminary efficacy of PSD506 in treatment-naïve or previously treated (washed out) patients with benign prostatic obstruction and lower urinary tract symptomsMen with LUTS and BPE/BOOUrological and Genital DiseasesBenign prostatic obstruction and lower urinary tract symptomsISRCTN71613863Plethora Solutions Limited (UK)88
进行中（未招募）
1 期
A double-blind, placebo-controlled pilot trial of BP1.4979 for the treatment of binge eating disorderBinge eating disorder (BED)MedDRA version: 24.0Level: PTClassification code 10004716Term: Binge eatingSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2021-000472-11-FRBIOPROJET PHARMA66
进行中（未招募）
1 期
A double-blind, placebo-controlled pilot trial of BP1.4979 for the treatment of binge eating disorder.Binge eating disorderMedDRA version: 21.1Level: PTClassification code: 10004716Term: Binge eating Class: 100000004873CTIS2023-506511-17-00Bioprojet Pharma86
进行中（未招募）
不适用
A double-blind, placebo controlled, pilot study to assess the safety and preliminary efficacy of PSD506 in treatment-naïve or previously treated (washed out) patients with benign prostatic obstruction (BPO) and lower urinary tract symptoms (LUTS) - NAThis study aims to assess the safety of PSD506 in men with benign prostatic enlargement (BPE) / benign prostatic obstruction (BPO) and lower urinary tract symptoms (LUTS) and an IPSS of 8-19, in line with Americian Association recommendations.MedDRA version: 8.1Level: LLTClassification code 10055026Term: Prostatic obstructionEUCTR2006-002055-32-DEPlethora Solutions Limited80
进行中（未招募）
1 期
A double-blind, placebo controlled, pilot study to assess the safety and preliminary efficacy of PSD506 in treatment-naïve or previously treated (washed out) patients with benign prostatic obstruction (BPO) and lower urinary tract symptoms (LUTS) - PSD506-OAB-004benign prostatic obstruction (BPO) and lower urinary tract symptoms (LUTS)MedDRA version: 8.1 Level: LLT Classification code 10055026 Term: Prostatic obstructionEUCTR2006-002055-32-IEPlethora Solutions Limited80